1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. THIRD HARMONIC BIO INC
Third Harmonic Bio Inc XNAS: THRD

Watchlist

Portfolio

Alert

Share


Insider Trading disclosures for Third Harmonic Bio Inc

The latest disclosure was made by Christopher M. Murphy in Third Harmonic Bio Inc where a trade of 30,000 Restricted Stock Unit done was reported to US exchanges on March 1, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Christopher M. Murphy Chief Financial & Bus. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2025 30,000 30,000 - - Restricted Stock Unit
Natalie C. Holles Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2025 400,000 400,000 - - Employee Stock Option (right to buy)
Natalie C. Holles Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2025 50,000 50,000 - - Restricted Stock Unit
Edward R. Conner Chief Medical Officer 15 Jan 2025 16,500 16,500 - - Restricted Stock Unit
Edward R. Conner Chief Medical Officer 15 Jan 2025 132,000 132,000 - - Employee Stock Option (right to buy)
Julie Person CHIEF ADMINISTRATIVE OFFICER 15 Jan 2025 100,000 100,000 - - Employee Stock Option (right to buy)
Julie Person CHIEF ADMINISTRATIVE OFFICER 15 Jan 2025 12,500 12,500 - - Restricted Stock Unit
Christopher M. Murphy Chief Financial & Bus. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2025 17,500 17,500 - - Restricted Stock Unit
Christopher M. Murphy Chief Financial & Bus. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2025 140,000 140,000 - - Employee Stock Option (right to buy)
Jennifer Dittman Chief Operating Officer 15 Jan 2025 92,000 92,000 - - Employee Stock Option (right to buy)
Jennifer Dittman Chief Operating Officer 15 Jan 2025 11,500 11,500 - - Restricted Stock Unit
Dennis Dean Chief Nonclinical Dev. Officer 15 Jan 2025 11,500 11,500 - - Restricted Stock Unit
Dennis Dean Chief Nonclinical Dev. Officer 15 Jan 2025 92,000 92,000 - - Employee Stock Option (right to buy)
Edward R. Conner Chief Medical Officer 08 Nov 2024 2,117 0 - 15 31,755 Common Stock
Edward R. Conner Chief Medical Officer 08 Nov 2024 2,117 2,117 - 4.2 8,891 Common Stock
Edward R. Conner Chief Medical Officer 08 Nov 2024 2,117 368,918 - - Employee Option Grant (right to buy)
Edward R. Conner Chief Medical Officer 28 Oct 2024 2,673 2,673 - 4.2 11,227 Common Stock
Edward R. Conner Chief Medical Officer 28 Oct 2024 2,673 371,035 - - Employee Option Grant (right to buy)
Edward R. Conner Chief Medical Officer 28 Oct 2024 2,673 0 - 15 40,095 Common Stock
Edward R. Conner Chief Medical Officer 19 Sep 2024 4,790 0 - 15 71,850 Common Stock
Edward R. Conner Chief Medical Officer 19 Sep 2024 4,790 4,790 - 4.2 20,118 Common Stock
Edward R. Conner Chief Medical Officer 19 Sep 2024 4,790 373,708 - - Employee Option Grant (right to buy)
Julie Person CHIEF ADMINISTRATIVE OFFICER 18 Sep 2024 503 0 - 14 7,042 Common Stock
Julie Person CHIEF ADMINISTRATIVE OFFICER 18 Sep 2024 503 503 - 4.2 2,113 Common Stock
Julie Person CHIEF ADMINISTRATIVE OFFICER 18 Sep 2024 9,497 155,962 - - Employee Option Grant (right to buy)
Julie Person CHIEF ADMINISTRATIVE OFFICER 18 Sep 2024 503 165,459 - - Employee Option Grant (right to buy)
Julie Person CHIEF ADMINISTRATIVE OFFICER 18 Sep 2024 9,497 0 - 14.3 135,685 Common Stock
Julie Person CHIEF ADMINISTRATIVE OFFICER 18 Sep 2024 9,497 9,497 - 4.2 39,887 Common Stock
Julie Person CHIEF ADMINISTRATIVE OFFICER 26 Jun 2024 10,000 10,000 - 4.2 42,000 Common Stock
Julie Person CHIEF ADMINISTRATIVE OFFICER 26 Jun 2024 10,000 165,962 - - Employee Option Grant (right to buy)
Julie Person CHIEF ADMINISTRATIVE OFFICER 26 Jun 2024 10,000 0 - 12.5 124,569 Common Stock
Jennifer Dittman Chief Development Oper Officer 07 Jun 2024 494 16,294 - - Employee Stock Option (right to buy)
Jennifer Dittman Chief Development Oper Officer 07 Jun 2024 494 0 - 14.2 7,000 Common Stock
Jennifer Dittman Chief Development Oper Officer 07 Jun 2024 494 494 - 4.2 2,075 Common Stock
Mark T. Iwicki Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2024 20,000 20,000 - - Director Stock Option (right to buy)
Thomas M. Soloway Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2024 20,000 20,000 - - Director Stock Option (right to buy)
David P. Bonita Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2024 20,000 20,000 - - Director Stock Option (right to buy)
Michael Gladstone Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2024 20,000 20,000 - - Director Stock Option (right to buy)
H. Martin Seidel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2024 20,000 20,000 - - Director Stock Option (right to buy)
Jennifer Dittman Chief Development Oper Officer 20 May 2024 1,042 0 - 14 14,588 Common Stock
Jennifer Dittman Chief Development Oper Officer 20 May 2024 1,042 1,042 - 4.3 4,481 Common Stock
Jennifer Dittman Chief Development Oper Officer 20 May 2024 1,042 32,292 - - Employee Stock Option (right to buy)
Jennifer Dittman Chief Development Oper Officer 16 May 2024 6,912 16,788 - - Employee Stock Option (right to buy)
Jennifer Dittman Chief Development Oper Officer 16 May 2024 16,666 33,334 - - Employee Stock Option (right to buy)
Jennifer Dittman Chief Development Oper Officer 16 May 2024 100,000 100,000 - - Employee Stock Option (right to buy)
Jennifer Dittman Chief Development Oper Officer 16 May 2024 23,578 0 - 14.0 331,066 Common Stock
Jennifer Dittman Chief Development Oper Officer 16 May 2024 6,912 23,578 - 4.2 29,030 Common Stock
Jennifer Dittman Chief Development Oper Officer 16 May 2024 16,666 16,666 - 4.3 71,664 Common Stock
Dennis Dean Chief Nonclinical Dev. Officer 16 May 2024 210,000 210,000 - - Employee Stock Option (right to buy)
Natalie C. Holles Director, CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 May 2024 20,222 433,854 - - Employee Stock Option (right to buy)
Natalie C. Holles Director, CEO Sale of securities on an exchange or to another person at price $ 12.18 per share. 09 May 2024 20,222 1,218,836 - 12.2 246,300 Common Stock
Natalie C. Holles Director, CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.20 per share. 09 May 2024 20,222 1,239,058 - 4.2 84,932 Common Stock
Natalie C. Holles Director, CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.20 per share. 11 Apr 2024 13,558 1,232,394 - 4.2 56,944 Common Stock
Natalie C. Holles Director, CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Apr 2024 13,558 454,076 - - Employee Stock Option (right to buy)
Natalie C. Holles Director, CEO Sale of securities on an exchange or to another person at price $ 12.19 per share. 11 Apr 2024 13,558 1,218,836 - 12.2 165,214 Common Stock
Julie Person CHIEF ADMINISTRATIVE OFFICER 04 Apr 2024 1,107 175,962 - - Employee Option Grant (right to buy)
Julie Person CHIEF ADMINISTRATIVE OFFICER 04 Apr 2024 1,107 1,107 - 4.2 4,649 Common Stock
Julie Person CHIEF ADMINISTRATIVE OFFICER 04 Apr 2024 1,107 0 - 10 11,070 Common Stock
Geoffrey McDonough Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Mar 2024 60,000 60,000 - - Stock Option (Right to Buy)
Julie Person Chief Administrative Officer 05 Jan 2024 116,000 116,000 - - Employee Option Grant (right to buy)
Christopher Murphy M. Chief Financial & Bus. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2024 410,000 410,000 - - Employee Option Grant (right to buy)
Edward R. Conner Chief Medical Officer 05 Jan 2024 133,000 133,000 - - Employee Option Grant (right to buy)
Natalie Holles C. Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2024 396,000 396,000 - - Employee Option Grant (right to buy)
C. Holles Natalie Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2024 396,000 396,000 - - Employee Option Grant (right to buy)
Person Julie Chief Administrative Officer 05 Dec 2023 12,863 12,863 - 4.2 54,025 Common Stock
Conner R. Edward Chief Medical Officer 05 Dec 2023 4,790 378,498 - - Employee Option Grant (right to buy)
Person Julie Chief Administrative Officer 05 Dec 2023 12,863 0 - 10.3 132,484 Common Stock
Person Julie Chief Administrative Officer 05 Dec 2023 12,863 67,137 - - Employee Option Grant (right to buy)
Conner R. Edward Chief Medical Officer 05 Dec 2023 4,790 4,790 - 4.2 20,118 Common Stock
Edward Conner R. Chief Medical Officer 05 Dec 2023 4,790 0 - 10.0 48,062 Common Stock
Mark T. Iwicki Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2023 16,250 16,250 - - Stock Option (right to buy)
Thomas M. Soloway Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2023 16,250 16,250 - - Stock Option (right to buy)
David P. Bonita Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2023 16,250 16,250 - - Stock Option (right to buy)
Michael Gladstone Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2023 16,250 16,250 - - Stock Option (right to buy)
H. Martin Seidel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2023 16,250 16,250 - - Stock Option (right to buy)
Mark T. Iwicki Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2023 35,413 35,413 - - Employee Stock Option (right to buy)
Mark T. Iwicki Director Sale or transfer of securities back to the company at price $ 0.00 per share. 06 Mar 2023 35,413 0 - - Employee Stock Option (right to buy)
Mark T. Iwicki Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2023 13,667 13,667 - - Employee Stock Option (right to buy)
Mark T. Iwicki Director Sale or transfer of securities back to the company at price $ 0.00 per share. 06 Mar 2023 13,667 0 - - Employee Stock Option (right to buy)
Robert J. Perez Director 06 Mar 2023 13,667 13,667 - - Employee Stock Option (right to buy)
Robert J. Perez Director 06 Mar 2023 13,667 0 - - Employee Stock Option (right to buy)
Thomas M. Soloway Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2023 76,582 76,582 - - Employee Stock Option (right to buy)
Thomas M. Soloway Director Sale or transfer of securities back to the company at price $ 0.00 per share. 06 Mar 2023 76,582 0 - - Employee Stock Option (right to buy)
Thomas M. Soloway Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2023 13,667 13,667 - - Employee Stock Option (right to buy)
Thomas M. Soloway Director Sale or transfer of securities back to the company at price $ 0.00 per share. 06 Mar 2023 13,667 0 - - Employee Stock Option (right to buy)
David P. Bonita Director, Ten Percent Owner Sale or transfer of securities back to the company at price $ 0.00 per share. 06 Mar 2023 13,667 0 - - Employee Stock Option (right to buy)
David P. Bonita Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2023 13,667 13,667 - - Employee Stock Option (right to buy)
Natalie C. Holles Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2023 205,000 205,000 - - Employee Stock Option (right to buy)
Natalie C. Holles Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2023 360,000 360,000 - - Employee Stock Option (right to buy)
Natalie C. Holles Director, CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 06 Mar 2023 467,634 0 - - Employee Stock Option (right to buy)
Natalie C. Holles Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2023 467,634 467,634 - - Employee Stock Option (right to buy)
Natalie C. Holles Director, CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 06 Mar 2023 205,000 0 - - Employee Stock Option (right to buy)
Edward R. Conner Chief Medical Officer 06 Mar 2023 383,288 383,288 - - Employee Stock Option (right to buy)
Edward R. Conner Chief Medical Officer 06 Mar 2023 137,000 137,000 - - Employee Stock Option (right to buy)
Edward R. Conner Chief Medical Officer 06 Mar 2023 95,000 95,000 - - Employee Stock Option (right to buy)
Edward R. Conner Chief Medical Officer 06 Mar 2023 383,288 0 - - Employee Stock Option (right to buy)
Edward R. Conner Chief Medical Officer 06 Mar 2023 95,000 0 - - Employee Stock Option (right to buy)
Robert Ho Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 06 Mar 2023 367,955 0 - - Employee Stock Option (right to buy)
Robert Ho Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2023 136,000 136,000 - - Employee Stock Option (right to buy)
Robert Ho Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2023 95,000 95,000 - - Employee Stock Option (right to buy)
Robert Ho Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 06 Mar 2023 95,000 0 - - Employee Stock Option (right to buy)
Robert Ho Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2023 367,955 367,955 - - Employee Stock Option (right to buy)
Michael Gladstone Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2023 13,667 13,667 - - Employee Stock Option (right to buy)
Michael Gladstone Director Sale or transfer of securities back to the company at price $ 0.00 per share. 06 Mar 2023 13,667 0 - - Employee Stock Option (right to buy)
Julie Person Chief Administrative Officer 06 Mar 2023 80,000 0 - - Employee Stock Option (right to buy)
Julie Person Chief Administrative Officer 06 Mar 2023 177,069 177,069 - - Employee Stock Option (right to buy)
Julie Person Chief Administrative Officer 06 Mar 2023 119,000 119,000 - - Employee Stock Option (right to buy)
Julie Person Chief Administrative Officer 06 Mar 2023 80,000 80,000 - - Employee Stock Option (right to buy)
Julie Person Chief Administrative Officer 06 Mar 2023 177,069 0 - - Employee Stock Option (right to buy)
Adrian S. Ray Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2023 95,000 95,000 - - Employee Stock Option (right to buy)
Adrian S. Ray Chief Scientific Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 06 Mar 2023 95,000 0 - - Employee Stock Option (right to buy)
Adrian S. Ray Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2023 309,871 309,871 - - Employee Stock Option (right to buy)
Adrian S. Ray Chief Scientific Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 06 Mar 2023 309,871 0 - - Employee Stock Option (right to buy)
Adrian S. Ray Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2023 132,000 132,000 - - Employee Stock Option (right to buy)
H. Martin Seidel Director Sale or transfer of securities back to the company at price $ 0.00 per share. 06 Mar 2023 13,667 0 - - Employee Stock Option (right to buy)
H. Martin Seidel Director Sale or transfer of securities back to the company at price $ 0.00 per share. 06 Mar 2023 6,640 0 - - Employee Stock Option (right to buy)
H. Martin Seidel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2023 6,640 6,640 - - Employee Stock Option (right to buy)
H. Martin Seidel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2023 13,667 13,667 - - Employee Stock Option (right to buy)
Mark T. Iwicki Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Oct 2022 13,667 13,667 - - Stock Option (right to buy)
Robert J. Perez Director 26 Oct 2022 13,667 13,667 - - Stock Option (right to buy)
Thomas M. Soloway Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Oct 2022 13,667 13,667 - - Stock Option (right to buy)
David P. Bonita Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Oct 2022 13,667 13,667 - - Stock Option (right to buy)
Shao-Lee Lin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Oct 2022 13,667 13,667 - - Stock Option (right to buy)
Michael Gladstone Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Oct 2022 13,667 13,667 - - Stock Option (right to buy)
H. Martin Seidel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Oct 2022 13,667 13,667 - - Stock Option (right to buy)
Natalie C. Holles Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Oct 2022 205,000 205,000 - - Employee Option Grant (right to buy)
Edward R. Conner Chief Medical Officer 25 Oct 2022 95,000 95,000 - - Employee Option Grant (right to buy)
Robert Ho Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Oct 2022 95,000 95,000 - - Employee Option Grant (right to buy)
Julie Person Chief Administrative Officer 25 Oct 2022 80,000 80,000 - - Employee Option Grant (right to buy)
Adrian S. Ray Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Oct 2022 95,000 95,000 - - Employee Option Grant (right to buy)
Adrian S. Ray Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Oct 2022 95,000 95,000 - - Employee Option Grant (right to buy)
David P. Bonita Director, Ten Percent Owner 19 Sep 2022 5,479,071 5,479,071 - - Common Stock
David P. Bonita Director, Ten Percent Owner 19 Sep 2022 1,342,065 0 - - Series B Preferred Stock
David P. Bonita Director, Ten Percent Owner 19 Sep 2022 2,441,407 0 - - Series A-3 Preferred Stock
David P. Bonita Director, Ten Percent Owner 19 Sep 2022 8,593,750 0 - - Series A-2 Preferred Stock
David P. Bonita Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 17.00 per share. 19 Sep 2022 300,000 5,779,071 - 17 5,100,000 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters